A Novel High-throughput Screening Assay for Discovery of Molecules That Increase Cellular Tetrahydrobiopterin

Overview

Journal J Biomol Screen

Publisher Sage Publications

Date 2011 Jun 23

PMID 21693765

Citations 2

Authors

Li Li

Yuhong Du

Wei Chen

Haian Fu

David G Harrison

Affiliations

Soon will be listed here.

Abstract

Tetrahydrobiopterin (BH(4)) is an essential cofactor for the nitric oxide (NO) synthases and the aromatic amino acid hydroxylases. Insufficient BH(4) has been implicated in various cardiovascular and neurological disorders. GTP cyclohydrolase 1 (GTPCH-1) is the rate-limiting enzyme for de novo biosynthesis of BH(4). The authors have recently shown that the interaction of GTPCH-1 with GTP cyclohydrolase feedback regulatory protein (GFRP) inhibits endothelial GTPCH-1 enzyme activity, BH(4) levels, and NO production. They propose that agents that disrupt the GTPCH-1/GFRP interaction can increase cellular GTPCH-1 activity, BH(4) levels, and NO production. They developed and optimized a novel time-resolved fluorescence resonance energy transfer (TR-FRET) assay to monitor the interaction of GTPCH-1 and GFRP. This assay is highly sensitive and stable and has a signal-to-background ratio (S/B) greater than 12 and a Z' factor greater than 0.8. This assay was used in an ultra-high-throughput screening (uHTS) format to screen the Library of Pharmacologically Active Compounds. Using independent protein-protein interaction and cellular activity assays, the authors identified compounds that disrupt GTPCH-1/GFRP binding and increase endothelial cell biopterin levels. Thus, this TR-FRET assay could be applied in future uHTS of additional libraries to search for molecules that increase GTPCH-1 activity and BH(4) levels.

Citing Articles

Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.

Xiong J, Pecchi V, Qui M, Ivanov A, Mo X, Niu Q Assay Drug Dev Technol. 2018; 16(2):96-106.

PMID: 29634317 PMC: 5865254. DOI: 10.1089/adt.2017.835.

High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.

Marin M, Du Y, Giroud C, Kim J, Qui M, Fu H Assay Drug Dev Technol. 2015; 13(3):155-66.

PMID: 25871547 PMC: 4410757. DOI: 10.1089/adt.2015.639.

References

Antoniades C, Shirodaria C, Crabtree M, Rinze R, Alp N, Cunnington C . Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation. 2007; 116(24):2851-9. DOI: 10.1161/CIRCULATIONAHA.107.704155. View

Benjamin E, Pruthi F, Olanrewaju S, Ilyin V, Crumley G, Kutlina E . State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents. J Biomol Screen. 2005; 11(1):29-39. DOI: 10.1177/1087057105280918. View

Du X, Edelstein D, Obici S, Higham N, Zou M, Brownlee M . Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006; 116(4):1071-80. PMC: 1395482. DOI: 10.1172/JCI23354. View

Widder J, Chen W, Li L, Dikalov S, Thony B, Hatakeyama K . Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res. 2007; 101(8):830-8. DOI: 10.1161/CIRCRESAHA.107.153809. View

Katusic Z, Duscio L, Nath K . Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci. 2008; 30(1):48-54. PMC: 2637534. DOI: 10.1016/j.tips.2008.10.003. View

Rickardson L, Wickstrom M, Larsson R, Lovborg H . Image-based screening for the identification of novel proteasome inhibitors. J Biomol Screen. 2007; 12(2):203-10. DOI: 10.1177/1087057106297115. View

Harada T, KAGAMIYAMA H, Hatakeyama K . Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity. Science. 1993; 260(5113):1507-10. DOI: 10.1126/science.8502995. View

Yoneyama T, Hatakeyama K . Decameric GTP cyclohydrolase I forms complexes with two pentameric GTP cyclohydrolase I feedback regulatory proteins in the presence of phenylalanine or of a combination of tetrahydrobiopterin and GTP. J Biol Chem. 1998; 273(32):20102-8. DOI: 10.1074/jbc.273.32.20102. View

Takaya T, Hirata K, Yamashita T, Shinohara M, Sasaki N, Inoue N . A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler Thromb Vasc Biol. 2007; 27(7):1632-7. DOI: 10.1161/ATVBAHA.107.142182. View

10.

Swick L, Kapatos G . A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J Neurochem. 2006; 97(5):1447-55. PMC: 2239266. DOI: 10.1111/j.1471-4159.2006.03836.x. View

11.

Li L, Rezvan A, Salerno J, Husain A, Kwon K, Jo H . GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide. Circ Res. 2009; 106(2):328-36. PMC: 2818799. DOI: 10.1161/CIRCRESAHA.109.210658. View

12.

Li C, Stocker R . Heme oxygenase and iron: from bacteria to humans. Redox Rep. 2009; 14(3):95-101. DOI: 10.1179/135100009X392584. View

13.

Channon K . Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med. 2004; 14(8):323-7. DOI: 10.1016/j.tcm.2004.10.003. View

14.

Hattori Y, Hattori S, Wang X, Satoh H, Nakanishi N, Kasai K . Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol. 2007; 27(4):865-70. DOI: 10.1161/01.ATV.0000258946.55438.0e. View

15.

Landmesser U, Dikalov S, Price S, McCann L, Fukai T, Holland S . Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111(8):1201-9. PMC: 152929. DOI: 10.1172/JCI14172. View

16.

Vasquez-Vivar J, Kalyanaraman B, Martasek P . The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res. 2003; 37(2):121-7. DOI: 10.1080/1071576021000040655. View

17.

Ozers M, Ervin K, Steffen C, Fronczak J, Lebakken C, Carnahan K . Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization. Mol Endocrinol. 2004; 19(1):25-34. DOI: 10.1210/me.2004-0256. View

18.

Gunther J, Du Y, Rhoden E, Lewis I, Revennaugh B, Moore T . A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding. J Biomol Screen. 2009; 14(2):181-93. PMC: 2731238. DOI: 10.1177/1087057108329349. View

19.

Maita N, Hatakeyama K, Okada K, Hakoshima T . Structural basis of biopterin-induced inhibition of GTP cyclohydrolase I by GFRP, its feedback regulatory protein. J Biol Chem. 2004; 279(49):51534-40. DOI: 10.1074/jbc.M409440200. View

20.

Arkin M, Randal M, DeLano W, Hyde J, Luong T, Oslob J . Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A. 2003; 100(4):1603-8. PMC: 149879. DOI: 10.1073/pnas.252756299. View